Where: Bldg 20, Auditorium
Description
A keynote lecture by Andre Nel, Distinguished Professor of Medicine and Director of Research at California Nanosystems Institute (CNSI), UC.
Nanoparticles have made a big impact on the development of immunotherapy for cancer and serious allergic disorders, demonstrating the ability to develop new therapeutics that are capable of boosting immunogenic effects in the setting of “cold” tumor microenvironments in solid cancers, as well as the ability to induce tolerogenic effects that suppress antigen-specific immune hyperreactivity in the setting of asthma or autoimmune disease. In this talk, Professor Nel will describe cancer immunotherapy from the perspective of inducing immunogenic cell death (ICD) by silicasome carriers and liposomes that provide an endogenous vaccination approach through the delivery of chemotherapeutic agents in combination with other active pharmaceutical ingredients. Immunogenic cell death leads to the activation of cytotoxic T-cells by the generation of “eat-me” and immunological danger signals, which can be further propagated at the TMI delivery site by additional interference in checkpoint and immune metabolic pathways. This intervention can increase the number of immunotherapy responders to checkpoint inhibitors, in addition to inducing immune memory that can eradicate tumor metastases.
The second part of his talk will focus on the induction of antigen-specific immune tolerance by liver-targeting tolerogenic nanoparticles, which leads to the generation of antigen-specific regulatory T cells and that can suppress allergic inflammation in the lung and autoimmune disease processes. Moreover, both treatment modalities, i.e., ICD-inducing nanocarriers and liver-targeting tolerogenic nanoparticles, can be used on the translational side to generate new therapeutics that can be implemented to treat two major disease processes by using contrasting design features.
THE KEYNOTE LECTURE SERIES
The keynote lectures are signature events taking place as part of a series of main lectures aligned with the program’s theme. Since 2010, 140 eminent international guest speakers, Nobel laureates, entrepreneurs, academics and distinguished local and regional leaders and decision-makers have addressed the audience.
Check out this event’s photo gallery!
Watch this Keynotes lecture!
Watch the podcast interview with Andre Nel!
Andre Nel
Andre Nel is a Distinguished Professor of Medicine and is Founder and Chief of the Division of Nanomedicine. Also, he is the Director of the University of California’s Center for Environmental Implications of Nanotechnology (UC CEIN), a $48 million National Science Foundation (NSF) and Environmental Protection Agency (EPA) funded multidisciplinary and multi-institutional center for nanosafety implementation in the US. His research interests are: (i) Nanomedicine and Nanobiology, including nanomaterial therapeutic devices and the study of nanomaterial properties that lead to biocompatible and biohazardous interactions in humans and the environment; (ii) The role of air pollutants in asthma, with particular emphasis on the part of ultrafine particle-induced oxidative stress in the generation of airway inflammation and asthma. Dr. Nel serves as Associate Editor of ACS Nano, an internationally recognized journal.
No resources found.
No links found.